```html

Wombat Disease (Mycobacterium bovis Infection): A Complete Medical Guide

Overview

Wombat disease is a colloquial name for infection with Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex that primarily causes tuberculosis (TB) in cattle and other animals, including wild marsupials such as wombats. In humans, the infection produces a form of zoonotic tuberculosis that is clinically indistinguishable from the more common M. tuberculosis pulmonary disease, but it can also affect lymph nodes, bones, joints, and the central nervous system.

Who it affects: Anyone exposed to infected animals or contaminated animal products can become infected, but the disease is most prevalent among:

• Agricultural workers, veterinarians, and wildlife‑rehabilitation staff.
• People living in rural or farming communities where cattle or wildlife testing positive for M. bovis is documented.
• Individuals with weakened immune systems (e.g., HIV infection, diabetes, or those on immunosuppressive therapy).

Prevalence: In high‑income nations, human M. bovis infection accounts for less than 2 % of all TB cases (CDC, 2022). In parts of Africa, Latin America, and Oceania where bovine TB control programs are limited, the proportion can rise to 10–15 % of TB notifications<sup>[1]</sup>. In Australia, where the term “wombat disease” originated, the incidence in humans is < 1 case per 1 million population per year, but wildlife surveillance shows M. bovis infection in up to 30 % of wild wombat colonies in some regions<sup>[2]</sup>.

Symptoms

The clinical picture mirrors that of classic pulmonary TB, but extrapulmonary manifestations are more common when infection is acquired via ingestion of contaminated meat or milk.

Pulmonary (lung) symptoms

• Persistent cough lasting > 3 weeks (often dry at first, later productive).
• Hemoptysis (coughing up blood) – an alarming sign.
• Chest pain that may worsen with deep breathing.
• Shortness of breath or wheezing, especially with advanced disease.
• Fever (often low‑grade, 37.5–38.5 °C) that may be intermittent.
• Night sweats and unexplained weight loss (often >10 % of body weight).
• Fatigue and general malaise.

Extrapulmonary symptoms

• Lymphadenitis – swollen, painless lymph nodes, usually cervical or supraclavicular.
• Bone & joint disease – back or joint pain, spinal deformities (Pott disease).
• Genitourinary TB – dysuria, flank pain, or infertility.
• Gastrointestinal involvement – abdominal pain, chronic diarrhea, weight loss.
• Central nervous system TB – persistent headache, confusion, seizures (rare but severe).

Causes and Risk Factors

Cause: Infection occurs when M. bovis‑laden material reaches the human body. The bacterium is acid‑fast, slow‑growing, and can survive for months in the environment.

Primary routes of transmission

1. Inhalation of aerosolized droplets from infected cattle, wildlife, or humans with active pulmonary disease.
2. Ingestion of unpasteurized milk, dairy products, or undercooked meat from infected animals.
3. Direct contact with lesions or bodily fluids of infected animals (e.g., during veterinary procedures, abattoir work, or wildlife handling).

Key risk factors

• Occupational exposure: farmers, abattoir workers, veterinarians, wildlife carers.
• Consumption of raw or unpasteurized dairy products from endemic regions.
• Living in or traveling to areas with known bovine TB outbreaks.
• Immunosuppression (HIV, organ transplant, chronic steroids, diabetes).
• Close contact with someone who has active TB, regardless of species.

Diagnosis

Because the clinical presentation overlaps with other forms of TB, laboratory confirmation is essential.

Initial clinical assessment

• Detailed exposure history (occupational, dietary, travel).
• Physical exam focusing on lungs, lymph nodes, spine, and abdomen.

Laboratory and imaging tests

1. Chest radiography – classic upper‑lobe infiltrates, cavitation, or nodules.
2. Sputum smear microscopy – Ziehl‑Neelsen stain for acid‑fast bacilli (AFB). Positive result suggests mycobacterial infection but does not differentiate species.
3. Culture – Gold standard. Samples are grown on Lowenstein‑Jensen or MGIT media; M. bovis takes 4–8 weeks to grow.
4. Polymerase chain reaction (PCR) & GeneXpert – Rapid detection of Mycobacterium complex DNA and rifampin resistance; species‑specific PCR (e.g., IS6110, RD9) can identify M. bovis.
5. Interferon‑γ release assays (IGRAs) – Detect immune response to Mycobacterium antigens; useful when BCG vaccination confounds tuberculin skin test.
6. Histopathology – Biopsy of lymph nodes or bone lesions showing caseating granulomas supports diagnosis.
7. Additional imaging – CT or MRI for extrapulmonary disease (spine, CNS).

Drug‑susceptibility testing (DST)

M. bovis is intrinsically resistant to pyrazinamide, a first‑line TB drug, making DST critical for regimen selection.

Treatment Options

Therapy follows the same principles as drug‑sensitive pulmonary TB but is adjusted for the pyrazinamide resistance.

Standard regimen (6‑9 months)

• Intensive phase (2 months) – Isoniazid (INH) + Rifampin (RIF) + Ethambutol (EMB). Pyrazinamide is omitted.
• Continuation phase (4–7 months) – INH + RIF (often extended to 7 months to ensure sterilization).

Dosages are weight‑based, per CDC/National TB Guidelines<sup>[3]</sup>.

Alternative & adjunctive therapies

• Fluoroquinolones (e.g., levofloxacin) for drug‑resistant or intolerant cases.
• Surgical intervention for extensive bone disease, abscesses, or refractory lymphadenitis.
• Corticosteroids in select CNS or pericardial TB to reduce inflammation.

Lifestyle & supportive care

• Directly observed therapy (DOT) to ensure adherence.
• Nutrition optimization – high‑protein diet, vitamin D supplementation (supports immune response).
• Smoking cessation – improves lung healing.
• Alcohol reduction – lowers hepatotoxicity risk with TB drugs.

Living with Wombat Disease (Mycobacterium bovis Infection)

Successful treatment hinges on adherence and monitoring. Below are practical tips for day‑to‑day management.

Medication adherence

• Set a daily alarm or use a medication‑tracking app.
• Keep a pillbox organized by day and dose.
• Inform your prescriber promptly of side‑effects (e.g., visual changes with ethambutol, liver enzyme elevations).

Monitoring side effects

• Baseline and monthly liver function tests (ALT, AST) while on INH and RIF.
• Visual acuity check at baseline and every 2 months if on ethambutol.
• Report numbness or tingling (possible INH‑induced neuropathy) – may need pyridoxine (vitamin B6) supplementation.

Daily health habits

• Eat balanced meals rich in fruits, vegetables, and lean protein.
• Stay hydrated – 2–3 L of water daily unless fluid‑restricted for other conditions.
• Engage in moderate activity (e.g., walking 30 min most days) as tolerated.
• Maintain good sleep hygiene (7–9 hours/night).

Social & emotional support

• Join a TB support group (many hospitals or public‑health departments offer virtual meetings).
• Consider counseling if anxiety or stigma is present.
• Inform close contacts so they can be screened and, if necessary, receive prophylaxis.

Prevention

Because M. bovis is a zoonosis, preventive measures target both animal reservoirs and human exposure.

• Animal health programs – Regular testing and culling of infected cattle, vaccination of wildlife where feasible (e.g., oral BCG for badgers, possums, and wombats).
• Food safety – Always pasteurize milk and dairy products; cook meat to an internal temperature of ≥ 71 °C (160 °F).
• Personal protective equipment (PPE) – Wear gloves, face shields, and N95 respirators when handling sick animals or tissue.
• Occupational screening – Annual TB skin test or IGRA for high‑risk workers.
• Public education – Community campaigns in endemic regions about the risks of raw dairy.

Complications

If left untreated or if therapy is incomplete, M. bovis infection can lead to serious, sometimes irreversible damage.

• Pulmonary cavitation – predisposes to massive hemoptysis and secondary bacterial infection.
• Spinal (Pott) disease – vertebral collapse, kyphosis, and possible paraplegia.
• Miliary TB – disseminated infection causing multi‑organ failure.
• Chronic osteomyelitis – persistent bone infection requiring surgical debridement.
• Infertility – genital tract TB can scar reproductive organs.
• Drug‑induced hepatotoxicity – may compound liver injury if infection is not controlled.

When to Seek Emergency Care

---

References

1. World Health Organization. Global Tuberculosis Report 2023. WHO; 2023.
2. Australian Department of Agriculture, Water and the Environment. Bovine Tuberculosis in Wildlife – 2022 Surveillance Summary. 2022.
3. Centers for Disease Control and Prevention. Treatment of Tuberculosis, 2022 Update. CDC; 2022.
4. Mayo Clinic. Tuberculosis (TB) – Symptoms, Causes, and Treatment. 2024.
5. Cleveland Clinic. Zoonotic Tuberculosis (Mycobacterium bovis). 2023.

```